2Bodor N, Buchwald P. Soft durg design: general principle and recent applications[J]. Medical Research Review, 2000,20(1):58-101.
3Buchwald P, Bodor N. Structure-based estimation of enzymatic hydrolysis rates and its application computer-aided retrometabolic drug design[J]. Pharmazie Die, 2000,55(3):210-217.
4Calvani M, Critelli L, Gallo G, et al. L-Carnitine esters as soft, broad-spectrum antimicrobial amphiphiles[J]. J Med Chem, 1998,41(13):2227-2233.
5Raatikainen MJP, Napolitano CA, Druzgala P, et al. Electrophysiological effects of a novel, short-acting and potent ester derivative of amiodarone, ATI-2001, in guinea pig isolated heart[J]. J Pharmacol Exp Ther, 1996,277(3):1454-1463.
6Little RJ, Bodor N, loftson T. Soft drugs based on hydrocortisone: the inactive metabolite approach and its application to steroidal antiinflammatory agents[J]. Pharmaceutical Research, 1999,16(6):961-967.
7Kitamura A, Sakamoto A, Inoue T, et al. Efficacy of an ultra-short-acting adrenoreceptor blocker (ONO-1101) in attenuating cardiovascular responses to endotracheal intubation[J]. Eur J Clin Pharmacol, 1997,51(6):467-471.
8Bodor N, Buchwald P, Huang MJ. Computer- assisted design of new drugs based on retrometabolic concepts[J]. SAR QSAR Environ Res, 1998,8(1-2):41-92.
